NEW YORK, NY / ACCESS Newswire / March 19, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Zynex, Inc.

NEW YORK CITY, NY / ACCESS Newswire / March 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...

Zynex specializes in non-invasive pain management and patient monitoring, with promising advancements. Read why I think ZYXI ...

Revealing a significant insider sell on March 18, Thomas Sandgaard, President at Zynex ZYXI, as per the latest SEC filing. What Happened: Sandgaard's recent Form 4 filing with the U.S. Securities and ...

Fintel reports that on March 12, 2025, Ladenburg Thalmann downgraded their outlook for Zynex (NasdaqGS:ZYXI) from Buy to ...

Law Offices of Howard G. Smith announces an investigation on behalf of Zynex, Inc. (“Zynex” or the “Company”) (NASDAQ: ZYXI) investors concerning the Company’s possible violations of ...

Zynex (ZYXI) delivered earnings and revenue surprises of -122.22% and 14.39%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Despite a net loss and TRICARE payment suspension, Zynex Inc (ZYXI) shows resilience with revenue growth and strategic ...

Zynex (NASDAQ:ZYXI – Get Free Report) had its price objective lowered by equities researchers at HC Wainwright from $17.00 to $15.00 in a research note issued on Wednesday,Benzinga reports. The ...

Zynex, Inc. (NASDAQ:ZYXI – Free Report) – Research analysts at HC Wainwright reduced their Q1 2025 earnings per share estimates for Zynex in a report issued on Wednesday, March 12th.

ZYNEX ($ZYXI) posted quarterly earnings results on Tuesday, March 11th. The company reported earnings of -$0.02 per share, missing estimates of $0.09 by $0.11. The ...

Zynex (ZYXI) stock drops as RBC Capital Market downgrades following the company's Q4 2024 earnings report. Read more here.